Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism

British Journal of Surgery

Volumn 97, Issue 10, 2010, Pages 1528-1534

  Waldmann, J ^a   Lopez C L ^a   Langer, P ^a   Rothmund, M ^a   Bartsch, D K ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; EVALUATION; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; RECURRENT DISEASE; THYMECTOMY; TREATMENT OUTCOME;

ADULT; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID HORMONE; PARATHYROIDECTOMY; RECURRENCE; THYMECTOMY; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 77957013502     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7154     Document Type: Article

References (34)

1. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997; 276: 404-407.
2. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck, Skarulis MC et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997; 6: 1169-1175.
3. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16: 363-371.
4. Kraimps JL, Duh QY, Demeure M, Clark OH. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 1992; 112: 1080-1086.
5. Asgharian B, Turner ML, Gibril F, Entsuah LK, Serrano J, Robert T. Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. J Clin Endocrinol Metab 2004; 89: 5328-5336.
6. Arnalsteen LC, Alesina PF, Quiereux JL, Farrel SG, Patton FN, Carnaille BM et al. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 2002; 132: 1119-1124.
7. Katai M, Sakurai A, Ikeo Y, Hashizume K. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res 2001; 33: 499-503.
8. Norton A, Venzon DJ, Berna MJ, Alexander HR, Frake DL, Libutti SK et al. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg 2008; 247: 501-510.
9. Norton JA, Cornelius MJ, Doppman JL, Maton PN, Gardener JD, Jensen RT. Effect of parathyroidectomy in patients with hyperparathyroidism and Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1: a prospective study. Surgery 1987; 102: 958-996.
10. Prinz RA, Gamvros O, Sellu D, Lynn JA. Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. Ann Surg 1981; 193: 26-29.
11. Proye C, Carnaille B, Quievreux JL, Combemale F, Oudar C, Lecomte-Houcke M. Late outcome of 304 consecutive patients with multiple gland enlargement in primary hyperparathyroidism treated by conservative surgery. World J Surg 1998; 22: 526-529.
12. Bartsch DK, Kopp I, Bergenfelz A, Rieder H, Münch K, Jäger K. MEN1 gene mutations in 12 MEN1 families and their associated tumours. Eur J Endocrinol 1998; 139: 416-420.
13. Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 2002; 20: 35-47.
14. Brandi ML, Aurbach GD, Fitzpatrick LA, Quarto R, Spiegel AM, Bliziotes MM et al. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl JMed 1986; 314: 1287-1289.
15. Waldmann J, Fendrich V, Habbe N, Bartsch DK, Slater EP, Kann PH et al. Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World J Surg 2009; 33: 1208-1218.
16. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Conte-Devolx B et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658-5671.
17. Hellman P, Skogseid B, Juhlin C, Akerström G, Rastad J. Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type1. World J Surg 1992; 16: 718-725.
18. Goudet P, Cougard P, Vergès B, Murat A, Carnaille B, Calender A et al. Hyperparathyroidism in multiple endocrine neoplasia type 1: surgical trends and results of a 256-patient series from Groupe D'Etude des Neoplasies Endocriniennes Multiples Study Group. World J Surg 2001; 25: 886-890.
19. Dotzenrath C, Cupisti K, Goretzki PE, Yang Q, Simon D, Ohmann C et al. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is more or less extended operation essential?. Eur J Surg 2001; 167: 173-178.
20. Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 2003; 134: 858-864.
21. Langer P, Wild A, Schilling T, Nies C, Rothmund M, Bartsch DK. [Multiple endocrine neoplasia type 1. Surgical therapy of the primary hyperparathyroidism. ] Chirurg 2004; 75: 900-906.
22. Tonelli F, Marcucci T, Fratini G, Tommasi MS, Falchetti A, Brandi ML. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple neoplasia type 1? Ann Surg 2007; 246: 1075-1082.
23. Rizzoli R, Green J III, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia type 1. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 1985; 78: 467-474.
24. Lee CH, Tseng LM, Chen JY, Hsiao HY, Yang AH. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol 2006; 13: 103-109.
25. O'Riordian DS, O'Brien T, Grant CS, Weaver A, Gharib H, van Heerden JA. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery 1993; 114: 1031-1037.
26. Clark OH, Way LW, Hunt TK. Recurrent hyperparathyroidism. Ann Surg 1976; 184: 391-402.
27. Sokol MS, Kavolius J, Schaaf M, D'Avis J. Recurrent hyperparathyroidism from benign neoplastic seeding: a review with recommendations for management. Surgery 1993; 113: 456-461.
28. Burgess JR, David R, Parameswaran V, Greenaway TM, Shepherd JJ. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 1998; 133: 126-129.
29. Akerström G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery 1984; 95: 14-21.
30. Hubbard JG, Sebag F, Maweja S, Henry JF. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 2006; 141: 235-239.
31. Wagner PK, Seesko HG, Rothmund M. Retransplantation of cryopreserved human parathyroid tissue. World J Surg 1991; 15: 751-755.
32. Burgess JR, Giles N, Shepherd JJ. Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 2001; 55: 689-693.
33. Powell AC, Alexander HR, Pingpank JF, Steinberg SM, Skarulis M, Bartlett DL et al. The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroididsm. Surgery 2008; 144: 878-883.
34. Habbe N, Waldmann J, Bartsch DK, Fendrich V, Rothmund M, Langer P. Multimodal treatment of sporadic and inherited neuroendocrine tumours of the thymus. Surgery 2008; 144: 780-785.